J.Safra Asset Management Corp Immunocore Holdings PLC Transaction History
J.Safra Asset Management Corp
- $1.31 Billion
- Q2 2025
A detailed history of J.Safra Asset Management Corp transactions in Immunocore Holdings PLC stock. As of the latest transaction made, J.Safra Asset Management Corp holds 12 shares of IMCR stock, worth $407. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12Holding current value
$407% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding IMCR
# of Institutions
128Shares Held
44.6MCall Options Held
219KPut Options Held
125K-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.05MShares$239 Million0.14% of portfolio
-
Wellington Management Group LLP Boston, MA6.13MShares$208 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$165 Million2.37% of portfolio
-
Primecap Management CO Pasadena, CA2.68MShares$90.9 Million0.07% of portfolio
-
Baker Bros. Advisors LP New York, NY2.32MShares$78.8 Million0.82% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.49B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...